Trial Profile
A phase I/IIa trial of ATX 101 in patients with superficial bladder cancer
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 12 Oct 2016
Price :
$35
*
At a glance
- Drugs ATX 101 (Primary)
- Indications Bladder cancer
- Focus Adverse reactions
- 12 Oct 2016 New trial record